|

Spectral Precise Image Study for Brain Tumors

RECRUITINGSponsored by Philips Clinical & Medical Affairs Global
Actively Recruiting
SponsorPhilips Clinical & Medical Affairs Global
Started2025-11-28
Est. completion2026-08-30
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07620470

Summary

The goal of this observational study is to explore the image quality of spectral CT deep learning reconstruction technology (Spectral Precise Image) of patients with confirmed brain tumors. The main question it aims to answer is: The Image Quality (IQ) and diagnostic confidence of Spectral Precise Image reconstructions

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Patients with clinical and radiology (MRI/CT) diagnosed brain tumors.
2. Patients who underwent contrast enhanced scans using the Spectral CT 7500.
3. Study participants with age ≥ 18 years old.
4. Study participants that have signed Informed Consent Form (ICF)

Exclusion Criteria:

1. The clinical data or radiological information is considered incomplete after evaluation by the investigator.
2. Study participant that was enrolled in this study in the past
3. Data from study participants deemed unsuitable for enrollment based on the investigator's evaluation

Conditions2

Brain TumorsCancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.